A Study of LY3471851 in Participants With Psoriasis
J1P-MC-KFAC - ClinicalTrials.gov - NCT04119557
The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with psoriasis.
Trial Summary
Age Range
18 - 70 yearsConditions the trial is for
Plaque PsoriasisWhat the trial is testing?
LY3471851Could I receive a Placebo?
YesEnrollment Goal
30Trial Dates
Nov 26, 2019 - Jul 21, 2021How long will I be in the trial?
The study will last up to 48 weeks and may include up to 23 visits to the study center.Trial Phase
IKey Requirements
Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.Participants Must:
Participants must have been diagnosed with psoriasis for at least 6 months
Participants must have active psoriasis plaques
Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)
Participants Must Not:
Participants must not have received certain medications for psoriasis that are applied to the skin within 14 days prior to baseline (Day 1)
Participants must not have received certain oral or injectable medications or light therapy for psoriasis within 4 weeks prior to baseline
Participants must not have taken the study drug previously
Lilly Trial Alerts
Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.
You will complete the questionnaire on another website.YesNo